Completed NA INTERVENTIONAL 2-arm NCT05201040

Evaluate the Safety and Effectiveness of Mannitol-combined Hyaluronan Supplement in the Treatment of Knee OA

A Prospective, Randomized, Evaluator/Subject-blinded, Double-Center, Controlled Clinical Study: Evaluate the Safety and Effectiveness of Mannitol-combined Hyaluronan Supplement in the Treatment of Knee Osteoarthritis.

Sponsor: SciVision Biotech Inc.

Conditions Hyaluronic Acid Knee Osteoarthritis

Interventions JETKNEE Synovial Fluid Supplement Normal saline

Updated 7 times since 2022 Last updated: Sep 11, 2023 Started: Nov 15, 2021 Primary completion: Jun 15, 2023 Completion: Jun 15, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Hyaluronic Acid and Knee Osteoarthritis and is currently completed. SciVision Biotech Inc. leads this study, which shows 7 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2023 — Jul 2024 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Jun 2023 — Oct 2023 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 2 earlier versions

Mar 2022 — Jun 2023 [monthly]

Recruiting NA
Feb 2022 — Mar 2022 [monthly]

Recruiting NA

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SciVision Biotech Inc.

Data source: SciVision Biotech Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kaohsiung City, Taiwan